Expect Pharma M&A to Rebound After COVID-19 Eases

The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially benefiting exchange traded funds, such as the SPDR S&P Pharmaceuticals ETF ( XPH B ) and the VanEck Vectors Pharmaceutical ETF ( PPH A- ).